Health Canada recently released a statement warning of potential psychotic reactions to ADHD medications. The public advisory also said that patient and labeling information will be changed to reflect "the potential for psychiatric adverse affects."

The new safety concerns come four months after Health Canada warned ADHD drugs can carry rare heart risks, including a risk of sudden death.

That public advisory cautioned that any child or adult with high blood pressure, heart disease or heart abnormalities, hardening of the arteries or an overactive thyroid gland should not use Ritalin or seven other medications. (Source: Canwest News Service)

The same drugs are mentioned in this new advisory: Ritalin and Ritalin SR, Adderall XR, Attenade, Biphentin, Concerta, Dexedrine and Strattera. Heath Canada expects label changes to be complete by December, Canwest News reported.

Labels: medications, dangers, Canada, warnings

Posted By: Aspen/CRC 0 Comments

Canada has launched it's first-ever Awareness Campaign to promote understanding, dispel myths and stimulate advocacy for ADHD. One of the main goals of the campaign is to increase the support that Canadian students with ADHD receive in the classroom.

"Currently in Ontario, a diagnosis of ADHD does not qualify a student for a special needs designation in most school boards. This designation gives these students the right to receive accommodations in the way they are taught and evaluated. There is also no consistency in Ontario on how children with ADHD are serviced or if they are serviced at all."

Heidi Bernhardt, national director for the Centre for ADHD Advocacy in Canada (CADDAC), hopes to use the Awareness Campaign as leverage to convince the Ministry of Education that educational changes need to be implemented. Kathleen Wynne, Minister of Education, recently acknowledged that the Ontario Human Rights Code requires school boards to accommodate students with ADHD.

Labels: awareness, Canada, advocacy

Posted By: Aspen Education Group 0 Comments